QualityStocks Stock Newsletters Archives - Page 678 of 1818

ThursdayOct 01, 2009 8:50 am

TransDigm Group Inc. (TDG) Prices Private Note Offering

TransDigm Group Inc. announced the pricing of its $425 million Senior Subordinated Notes issue. The issue is a private offering that will close on October 6, 2009. TransDigm Group will use the proceeds of the offering to pay a special dividend to holders of its common stock. The amount of the special dividend will be in a range of $7.50-7.70. The bonds are exempt from registration under Rule 144A of the Securities Act of 1933. The company reported earnings of $0.82 in its fiscal third quarter that ended 6/27/2009. This was up 14% from the same quarter last year. Revenues…

ThursdayOct 01, 2009 8:45 am

iTech Medical, Inc. (IMSU.OB) Announces Update on MPR Clinical Development

The California based company iTech Medical has been gaining national recognition of late as being a leader in the medical information technology field. Today, iTech Medical took a major step towards enhancing their future when they provided an update on their clinical and regulatory plans for their proprietary Muscle Pattern Recognition (MPR) System. The MPR system is unique in that it is a patented clinical tool that analyzes patterns of muscles recruit and, more importantly, provides detailed physiological information on muscle function that can assist in the diagnosis and treatment of back and neck injury and illness. Currently, iTech is…

WednesdaySep 30, 2009 2:01 pm

ONE Holdings Corp. (ONEZ.OB) Announces Acquisition of Jianou Lujian FoodsStuff

Today, ONE Holdings Corp. announced it has closed on the acquisition of Jianou Lujian FoodsStuff Co. Ltd., effective September 27th, 2009. The announcement occurred under a letter of intent dated August 18, 2009. ONE's Vice Chairman and CEO, Marius Silvasan, stated, "Our objective was to close on the acquisition of JLF prior to the end of the third quarter and we did that. JLF is our third acquisition in the last three months. Through these initial key acquisitions we have set up a strong foundation and positioned ourselves with key operating assets which we expect will drive both strong organic…

WednesdaySep 30, 2009 11:54 am

Magnum D’Or Resources, Inc. (MDOR) Fat Contracts Prompt Personnel Additions

Magnum D'Or Resources, Inc. is an innovator in rubber reprocessing with the logistical capacity to easily satisfy its 5-year, $131.2 million in open contracts for the production of rubber buffings and nuggets. However, as Magnum President and CEO Joseph Glusic recently stated, the infrastructural expansion this capital represents demands the immediate retention of several key personnel. • Dr. Hugh Campbell, Engineering and Science • Curtis Basner, Operations and Procedure • Thomas Hillmer, Environmental Compliance • Paul Miles, Quality Assurance • Donald Kot, Transportation and Procurement • Donald Brinkmann, Architectural Design and Construction Glusic expressed his excitement to be working with…

WednesdaySep 30, 2009 10:45 am

Hana Biosciences, Inc. (HNAB.OB) Attacks Pediatric Cancer

If there is one disease that has plagued our country and people across the globe, it would be cancer. Perhaps there is not a more tragic situation than when a child is stricken down with the deadly disease. One company is trying to make headway into Pediatric Cancer. That company is Hana Biosciences. The San Francisco based Hana Biosciences is a biopharmaceutical company that has dedicated their resources and time to developing and commercializing new and differentiated cancer therapies with a plan to improve and enable standards of care amongst cancer patients. Hana took a major step towards achieving this…

WednesdaySep 30, 2009 10:41 am

Classic Costume Company, Inc. (CCUC.OB) Reports $534K in Orders from Operations of Subsidiary Imperial Coach Works, Inc.

Classic Costume Company, Inc., a business development, marketing and manufacturing conglomerate focused on providing 100 percent electric vehicle and powertrain technologies, recently announced that the company received $534K in signed purchase orders from Imperial Coach Works, Inc. for the months of July and August 2009. Completion of these purchase orders is estimated to take place within 60 to 90 days from date of execution and will be reported as actual revenues in the fourth quarter report of this year. Working to build a dominating presence in the aftermarket automotive up-fitter segment, including “Pure Electric” vehicles, limousines, other livery, specialty fleet…

WednesdaySep 30, 2009 10:40 am

Anavex Life Sciences Corp. (AVXL.OB) Contracts FORENAP for Clinical Trials of Their Alzheimer’s Drug

Swiss-based drug company Anavex Life Sciences Corp. announced today that they have selected FORENAP Pharma as the contract research organization for Phase 1 clinical trials of ANAVEX 2-73, the company's lead Alzheimer's drug candidate. FORENAP has been involved in pre-clinical and clinical research for 20 years and is renowned for its expertise in central nervous system studies, including Alzheimer's disease. FORENAP will perform study setup, protocol review, site monitoring and project management for the trials. Rudy Luthringer, CEO of FORENAP, said, “We look forward to running a high-quality and cost-effective program as Anavex works to confirm its pre-clinical findings in…

WednesdaySep 30, 2009 10:32 am

Caraco Pharmaceutical Laboratories Inc. (CPD) Gets Back on Track in Generic Drug Market

Companies often stumble in certain areas only to come back stronger and more profitable as issues are addressed and overcome. In certain areas, this particular type of problem is more easily overcome then in others, especially when the profit potential is exceedingly large. The generic drug market is one such area and one that will be extremely profitable in coming years. Caraco Pharmaceutical Laboratories Inc., a generic drug manufacturer, works to provide generic drugs to a host of mass merchant pharmacy outlets, warehouses, wholesalers and distributors. The company offers a wide array of generic prescription drugs targeted at main stream…

WednesdaySep 30, 2009 10:24 am

Alexza Pharmaceuticals, Inc. (ALXA) To Raise $19 Million in Equity

Alexza Pharmaceuticals, Inc. announced a private placement equity offering of 8.1 million shares of common stock to several qualified institutional investors. The company will receive $2.4325 per share, or approximately $19.1 million in net proceeds. Alexza Pharmaceuticals also issued 7.3 million warrants as part of the deal. The warrants entitle the holder to purchase 0.9 shares of common stock at $2.77 per share. The warrants expire in seven years. Alexza Pharmaceuticals is developing a proprietary drug delivery technology called the Staccato® system. This technology vaporizes unformulated pharmaceutical drugs into an aerosol form that allows rapid systemic delivery through lung inhalation.…

WednesdaySep 30, 2009 10:01 am

XFormity Technologies, Inc. (XFMY.OB) Reports Record Financial Results for Year Ending June 2009

XFormity Technologies, Inc., a leading provider of technology services to multi-unit restaurant organizations, today reported its financial results for its fiscal year ending June 30, 2009. The report showed continued revenues and profits growing at a record pace. The company’s revenues for the year totaled $1,978,231 a 36% increase over the year ending June 2008 with revenues of $1,457,884. “We are very pleased with the direction of the company and with our continued revenue growth” stated Chris Ball XFormity’s CEO. There was also a significant improvement in net profit, with the annual net profit of $786,508 a 162% increase over…

Site Search

Company Search

Category: QualityStocks Stock Newsletters